Crescent Biopharma, Inc. (CBIO) stock
CBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$13.04−0.46 (-3.41%)
Close on Nov 17, 2026Market cap $484.36MP/E –Yield –
Crescent Biopharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Crescent Biopharma's price to book ratio was 2.5× on Nov 11, 2026, against 1.8× a year earlier. Over the last 5 years it ranged from 1.1× to 484.4×, with a median of 77.2×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.5× | +1.1 |
| 2025 | Dec 31, 2025 | 1.4× | −130.4 |
| 2024 | Oct 31, 2024 | 131.8× | −194.6 |
| 2023 | Dec 29, 2023 | 326.4× | −3.8 |
| 2022 | Dec 30, 2022 | 330.1× | +253.0 |
| 2021 | Dec 31, 2021 | 77.2× | −52.9 |
| 2020 | Dec 31, 2020 | 130.1× | −7.2 |
| 2019 | Dec 31, 2019 | 137.3× | −50.0 |
| 2018 | Dec 31, 2018 | 187.3× | −238.2 |
| 2017 | Nov 30, 2017 | 425.5× | +88.5 |
| 2016 | Dec 30, 2016 | 337.0× | +113.4 |
| 2015 | Dec 31, 2015 | 223.6× | −12.1 |
| 2014 | Dec 31, 2014 | 235.7× | – |
See a number that looks wrong?